肾移植后的免疫抑制的临床试验
总计372个结果
-
Novartis Pharmaceuticals完全的肾移植美国, 德国, 英国, 比利时, 澳大利亚, 匈牙利, 荷兰, 瑞典, 哥伦比亚, 阿根廷, 巴西, 加拿大, 丹麦, 大韩民国, 葡萄牙
-
Irmandade Santa Casa de Misericórdia de Porto AlegreNovartis完全的
-
University of Oslo School of PharmacyRikshospitalet University Hospital完全的
-
Novartis Pharmaceuticals完全的
-
University of Wisconsin, Madison完全的
-
The Second Artillery General HospitalCapital Medical University; Shanghai Changzheng Hospital; Air Force General Hospital of the PLA; Pharmacology Research Institute 和其他合作者完全的
-
Novartis Pharmaceuticals完全的
-
Brigham and Women's HospitalGenzyme, a Sanofi Company完全的
-
Wyeth is now a wholly owned subsidiary of Pfizer完全的
-
University Hospital MuensterElse Kröner Fresenius Foundation完全的
-
University Hospital, AntwerpNovartis Pharmaceuticals; University of Liege; University Hospital, Ghent; Universitair Ziekenhuis... 和其他合作者未知
-
General Hospital of Ningxia Medical University未知Characterize and Evaluate Functional After Transplantation | Determine the Therapeutic Efficiency | Correlate the Imaging Results中国
-
University Hospital, AntwerpWyeth is now a wholly owned subsidiary of Pfizer; Hoffmann-La Roche未知
-
Novartis Pharmaceuticals完全的